Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc

Strides will significantly expand its niche offerings on its front-end, which has grown multi-fold to attain a quarterly revenue size of USD 66 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news